Nota Bene Cancer - Dépistage, diagnostic et pronostic Flux RSS de Nota Bene Cancer http://www.e-cancer.fr/nota-bene-cancer2/depistage Sat, 25 May 2013 11:27:37 +0000 Joomla! 1.5 - Open Source Content Management fr-fr Thu, 23 May 2013 00:00:00 +0000 High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12188 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12188 Evaluation des technologies et des biomarqueurs Thu, 23 May 2013 00:00:00 +0000 Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12204 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12204 Politiques et programmes de dépistage Thu, 23 May 2013 00:00:00 +0000 Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12208 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12208 Essais de technologies et de biomarqueurs dans un contexte clinique Thu, 23 May 2013 00:00:00 +0000 Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12227 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12227 Découverte de technologies et de biomarqueurs Thu, 23 May 2013 00:00:00 +0000 Strategies for expanding colorectal cancer screening at community health centers http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12255 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12255 Ressources et infrastructures (Dépistage) Thu, 23 May 2013 00:00:00 +0000 Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12200 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12200 Evaluation des technologies et des biomarqueurs Thu, 23 May 2013 00:00:00 +0000 Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12218 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12218 Politiques et programmes de dépistage Thu, 23 May 2013 00:00:00 +0000 Effect of Age, Tumor Risk, and Comorbidity on Competing Risks for Survival in a U.S. Population–Based Cohort of Men With Prostate Cancer http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12223 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12223 Essais de technologies et de biomarqueurs dans un contexte clinique Thu, 23 May 2013 00:00:00 +0000 viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12250 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12250 Découverte de technologies et de biomarqueurs Thu, 23 May 2013 00:00:00 +0000 Patient Autonomy and Incidental Findings in Clinical Genomics http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12267 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12267 Ressources et infrastructures (Dépistage) Thu, 23 May 2013 00:00:00 +0000 Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the international mRCC database consortium criteria http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12214 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12214 Evaluation des technologies et des biomarqueurs Thu, 23 May 2013 00:00:00 +0000 “The Older, the Wiser” in Prostate Cancer Treatment Choices? http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12217 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12217 Essais de technologies et de biomarqueurs dans un contexte clinique Thu, 23 May 2013 00:00:00 +0000 Low expression of LOC285194 is associated with poor prognosis in colorectal cancer http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12256 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12256 Découverte de technologies et de biomarqueurs Thu, 23 May 2013 00:00:00 +0000 Clinical Genomic Database http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12271 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12271 Ressources et infrastructures (Dépistage) Thu, 23 May 2013 00:00:00 +0000 Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12220 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12220 Essais de technologies et de biomarqueurs dans un contexte clinique Thu, 23 May 2013 00:00:00 +0000 Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12235 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12235 Evaluation des technologies et des biomarqueurs Thu, 23 May 2013 00:00:00 +0000 Genetic screens to identify pathogenic gene variants in the common cancer predisposition Lynch syndrome http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12259 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12259 Découverte de technologies et de biomarqueurs Thu, 23 May 2013 00:00:00 +0000 Ethics and Genomic Incidental Findings http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12274 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12274 Ressources et infrastructures (Dépistage) Thu, 23 May 2013 00:00:00 +0000 Risk factors for recurrence after lung cancer resection as estimated using the survival tree method http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12226 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12226 Essais de technologies et de biomarqueurs dans un contexte clinique Thu, 23 May 2013 00:00:00 +0000 Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12244 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12244 Evaluation des technologies et des biomarqueurs Thu, 23 May 2013 00:00:00 +0000 Should we sequence everyone’s genome? No http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12282 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12282 Ressources et infrastructures (Dépistage) Thu, 23 May 2013 00:00:00 +0000 Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12232 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12232 Essais de technologies et de biomarqueurs dans un contexte clinique Thu, 23 May 2013 00:00:00 +0000 Assessment of multidrug resistance on cell coculture patterns using scanning electrochemical microscopy http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12263 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12263 Evaluation des technologies et des biomarqueurs Thu, 23 May 2013 00:00:00 +0000 Should we sequence everyone’s genome? Yes http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12286 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12286 Ressources et infrastructures (Dépistage) Thu, 23 May 2013 00:00:00 +0000 Mutations and prognosis in primary myelofibrosis http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12238 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12238 Essais de technologies et de biomarqueurs dans un contexte clinique Thu, 23 May 2013 00:00:00 +0000 Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12247 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12247 Essais de technologies et de biomarqueurs dans un contexte clinique Thu, 23 May 2013 00:00:00 +0000 Importance of Genetics in the Clinical Management of Chronic Myelomonocytic Leukemia http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12246 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12246 Essais de technologies et de biomarqueurs dans un contexte clinique Thu, 23 May 2013 00:00:00 +0000 C-Reactive Protein, Lipid-soluble Micronutrients, and Survival in Colorectal Cancer Patients http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12260 http://www.e-cancer.fr/nota-bene-cancer2?task=publication&idRec=12260 Essais de technologies et de biomarqueurs dans un contexte clinique Thu, 23 May 2013 00:00:00 +0000